Hinge Health (HNGE) Insider Group Sells $7.9M of Stock

Insight Holdings Executes Planned Sale of Hinge Health Stock

LLC Insight Holdings Group parted with 112,477 shares of Hinge Health, Inc. (NYSE: HNGE) on June 23, 2026. The transaction took place under a pre-arranged trading plan, with the shares crossing hands at an average price of $70.21. The total value of this specific sale reached roughly $7.90 million, adding to a busy string of portfolio adjustments by the group throughout the month.

Recent Insider Transaction History

This June trade joins multiple other moves logged by LLC Insight Holdings Group during the same period. Earlier in the month on June 22, the group sold 224,399 shares for about $15.92 million. Subsequent filings showed both additional purchases and sales, including a larger sale of 1,466,667 shares on June 29 valued at around $121.49 million, alongside smaller acquisitions to manage their overall stake in the San Francisco-based healthcare technology firm.

Stock Valuation and Price Levels

Hinge Health shares have experienced notable swings, trading between a 52-week low of $30.08 and a peak of $107.00. At the time of the June transactions, the stock traded around $70.56, placing it below its 50-day moving average of $92.61 while remaining above its 200-day moving average of $63.29. The company commands a market capitalization in the billions, carrying a price-to-earnings ratio of 34.64 based on recent financial results.

Wall Street Analyst Views and Price Targets

Analyst firms have kept a close watch on the health information provider, updating their expectations across the summer and autumn. On October 16, 2026, Keybanc maintained its Overweight rating while lifting its target to $140.00 from $125.00. Barclays also kept an Overweight rating on October 12, taking its target to $110.00. Needham followed on September 30 by keeping a Buy rating and raising its target to $115.00, while Baird held a Neutral rating with a $90.00 target on September 22. Additional updates came from Stifel with a $115.00 target on September 8, Truist Securities at $112.00 on August 11, and both RBC Capital and Citizens adjusting targets earlier in August.

Business Focus and Future Outlook

Founded in 2012, Hinge Health builds automated care delivery systems focused on musculoskeletal health care, utilizing AI-powered motion tracking and wearable technology to help self-insured employers address chronic pain and injury rehabilitation. The company is scheduled to report its next set of quarterly financial results on November 2, 2026, which may offer further clarity on its operational growth and revenue trajectory following a reported $720.06 million in trailing revenue.